Improvement in lung diffusion by endothelin A receptor blockade at high altitude

Journal of Applied Physiology

Volumn 112, Issue 1, 2012, Pages 20-25

  De Bisschop, Claire ^a   Martinot, Jean Benoit ^b   Leurquin Sterk, Gil ^c   Faoro, Vitalie ^c   Guénard, Hervé ^d   Naeije, Robert ^c  

^a UNIVERSITÉ DE POITIERS   (France)

^b Clinique & Maternite Sainte Elisabeth Namer   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Exercise capacity; Gas exchange; Hypoxia; Lung diffusion; Pulmonary capillary pressure; Pulmonary hypertension; Pulmonary vascular resistance

Indexed keywords

ENDOTHELIN A RECEPTOR; ISOXAZOLE DERIVATIVE; SITAXSENTAN; THIOPHENE DERIVATIVE;

ADULT; ALTITUDE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG EFFECT; EXERCISE TOLERANCE; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; MALE; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALTITUDE; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; RECEPTOR, ENDOTHELIN A; THIOPHENES; YOUNG ADULT;

EID: 84855402616     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00670.2011     Document Type: Article

References (51)

1. Agostoni P, Bussotti M, Cattadori G, Margutti E, Contini M, Muratori M, Marenzi G, Fiorentini C. Gas diffusion and alveolar-capillary unit in chronic heart failure. Eur Heart J 27: 2538-2541, 2006.
2. Agostoni P, Swenson ER, Bussotti M, Revera M, Meriggi P, Faini A, Lombardi C, Bilo G, Giuliano A, Bonacina D, Modesti PA, Mancia G, Parati G. High altitude exposure of three weeks duration increases lung diffusing capacity in humans. J Appl Physiol 110: 1564-1571, 2011.
3. Aguilaniu B, Maitre J, Glénet S, Gegout-Petit A, Guénard H. European reference equations for CO and NO lung transfer. Eur Respir J 31: 1091-1097, 2008.
4. Barst RJ. Sitaxsentan: A selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother 8: 95-109, 2007. (Pubitemid 46070832)
5. Berger MM, Rozendal CS, Schieber C, Dehler M, Zügel S, Bardenheuer HJ, Mairbäurl H. The effect of endothelin-1 on alveolar fluid clearance and pulmonary edema foremation in the rat. Anesth Analg 108: 225-231, 2009.
6. Borland CD, Dunningham H, Bottrill F, , Vuylsteke A, Yilmaz C, Dane DM, Hsia CC. Significant blood resistance to nitric oxide transfer in the lung. J Appl Physiol 108: 1052-1060, 2010.
7. Caillaud C, Serre-Cousine O, Anselme F, Capdevilla X, Prefaut C. Computerized tomography and pulmonary diffusing capacity in highly trained athletes after performing a triathlon. J Appl Physiol 79: 1226-1232, 1995.
8. Carlsen E, Comroe JH Jr. The rate of uptake of carbon monoxide and of nitric oxide by normal human erythrocytes and experimentally produced spherocytes. J Gen Physiol 42: 83-107, 1958.
9. Ceridon ML, Beck KC, Olson TP, Bilezikian JA, Johnson BD. Calculating alveolar capillary conductance and pulmonary capillary blood volume: Comparing the multiple- and single-inspired oxygen tension methods. J Appl Physiol 109: 643-653, 2010.
10. Cerny FC, Dempsey JA, Reddan WG. Pulmonary gas exchange in nonnative residents of high altitude. J Clin Invest 52: 2993-2999, 1973.
11. Comellas AP, Briva A, Dada LA, Butti ML, Trejo HE, Yshii C, Azzam ZS, Litvan J, Chen J, Lecuona E, Pesce LM, Yanagisawa M, Snajder JL. Endothelmin-1 impairs alveolar epithelial function via endothelial ETB receptor. Am J Respir Crit Care Med 179: 113-122, 2009.
12. De Bisschop C, Kiger L, Marden MC, Aata A, Huez S, Faoro V, Martinot JB, Naeije R, Guénard H. Pulmonary capillary blood volume and membrane conductance in Andeans and lowlanders at high altitude: A cross-sectional study. Nitric Oxide 23: 187-193, 2010.
13. DeGraff AC, Grover RF, Johnson RL, Hammond JW, Miller JM. Diffusing capacity of the lung in Caucasians native to 3,100 m. J Appl Physiol 29: 71-76, 1970.
14. Dehnert C, Luks AM, Schendler G, Menold E, Berger MM, Mairbäurl H, Faoro V, Bailey DM, Castell C, Hahn G, Vock P, SwensonER, Bärtsch P. No evidence for interstitial lung oedema by extensive pulmonary function testing at 4559 m. Eur Respir J 35: 812-820, 2010.
15. Dempsey JA, Reddan WG, Birnbaum ML, Forster HV, Thoden JS, Grover RF, Rankin J. Effects of acute through life-long hypoxic exposure on exercise pulmonary gas exchange. Respir Physiol 13: 62-89, 1971.
16. Eldridge MW, Braun RK, Yoneda KY, Walby WF. Effects of altitude and exercise on pulmonary capillary integrity: Evidence for subclinical high-Altitude pulmonary edema. J Appl Physiol 100: 972-980, 2006. (Pubitemid 43671554)
17. Forster RE. Diffusion of gases across the alveolar membrane. In: Handbook of Physiology. The Respiratory System. Gas Exchange. Bethesda, MD: Am Physiol Soc, 1987, vol. IV, chapt. 5, p. 71-88.
18. Galié N, Hoeper MM, Humbert Torbicki A M, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34: 1219-1263, 2009.
19. Galie N, Hoeper M, Gibbs JS, Simonneau G. Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Liver toxicity of sitaxsentan in pulmonary arterial hypertension. Eur Respir J 37: 475-476, 2011.
20. Ge RL, Matsuzawa Y, Takeoka M, Kubo K, Sekiguchi M, Kobayashi T. Low pulmonary diffusing capacity in subjects with acute mountain sickness. Chest 111: 58-64, 1997. (Pubitemid 27043607)
21. Glenet SN, de Bisschop C, Vargas F, Guenard HJ. Deciphering the nitric oxide to carbon monoxide lung transfer ratio: Physiological implications. J Physiol 582: 767-775, 2007. (Pubitemid 47040559)
22. Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, Houston CS. Operation Everest II: Elevated high altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol 63: 521-530, 1987. (Pubitemid 17161952)
23. Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD. The Effects of Phosphodiesterase-5 Inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 44: 2339-2348, 2004. (Pubitemid 39647608)
24. Guenard H, Varene N, Vaida P. Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer. Respir Physiol 70: 113-120, 1987. (Pubitemid 18008476)
25. Guleria JS, Pande JN, Sethi PK, Roy SB. Pulmonary diffusing capacity at high altitude. J Appl Physiol 31: 536-543, 1971.
26. Hopkins SR. Pulmonary edema does occur in athletes performing heavy sea level exercise. J Appl Physiol 109: 1270-1072, 2010.
27. Johns DP, Berry D, Maskrey M, Wood-Baker R, Reid DW, Walters EH, Walls J. Decreased lung capillary blood volume post-exercise is compensated by increased membrane diffusing capacity. Eur J Appl Physiol 93: 96-101, 2004. (Pubitemid 39485584)
28. Kohan DE. Endothelins, renal tubule synthesis and actions. Clin Exp Pharmacol Physiol 23: 337-344, 1996. (Pubitemid 26170089)
29. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26: 720-735, 2005. (Pubitemid 41448672)
30. Maggiorini M, Mélot C, Pierre S, Pfeiffer F, Greve I, Sartori C, Lepori M, Hauser M, Scherrer U, Naeije R. High altitude pulmonary edema is initially caused by an increased capillary pressure. Circulation 103: 2078-2083, 2001. (Pubitemid 32373011)
31. Manier G, Moinard J, Stoïcheff H. Pulmonary diffusing capacity after maximal exercise. J Appl Physiol 75: 2580-2585, 1993. (Pubitemid 24008375)
32. Modesti PA, Vanni S, Morabito Modesti A Marchetta M, Gamberi M, Sofi T, Savia F, Mancia G, Gensini, G, Parati GF. Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation 114: 1410-1416, 2006. (Pubitemid 44454561)
33. Moinard J, Guenard H. Determination of lung capillary blood volume and membrane diffusing capacity in patients with COLD using the NO-CO method. Eur Respir J 3: 318-322, 1990. (Pubitemid 20128553)
34. Naeije R, Huez S, Lamotte M, Retailleau K, Neupane S, Abramowicz D, Faoro V. Pulmonary artery pressure limits exercise capacity at high altitudes. Eur Respir J 36: 1049-1055, 2010.
35. Puri S, Baker BL, Dutka DP, Oakley CM, Hughes JM, Cleland JG. Reduced alveolo-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation 91: 2769-2774, 1995.
36. Roach RC, Bärtsch P, Hackett PH, Oelz O. The Lake Louise acute mountain sickness scoring system. In: Hypoxia and Mountain Medicine, edited by Sutton JR, Houston CS, and Coates G. Burlington, VT: Queen City, 1993, p. 327-330.
37. Roughton FJW, Forster RE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol 11: 290-302, 1957.
38. Sheel AW, Coutts KD, Potts JE, McKenzie DC. The time course of pulmonary diffusing capacity for carbon monoxide following short duration high intensity exercise. Respir Physiol 111: 271-281, 1998.
39. Snyder EM, Olson TP, Johnson BD, Frantz RP. Influence of sildenafil on lung diffusion during exposure to acute hypoxia at rest and during exercise in healthy humans. Eur J Appl Physiol 103: 421-430, 2008.
40. Stewart IB, Potts JE, McKenzie DC, Coutts KD. Effect of body position on measurements of diffusion capacity after exercise. Br J Sports Med 34: 440-444, 2000.
41. Tzani P, Aiello M, Colella M, Verduri A, Marangio E, Olivieri A. Lung diffusing capacity can predict maximal exercise in apparently healthy smokers. J Sports Sci Med 7: 229-234, 2008.
42. Van der Zee L, Zanen P, Biesma DH, van den Bosch JM. The effect of red cell transfusion on nitric oxide diffusing capacity. Respiration 72: 512-516, 2005. (Pubitemid 41433567)
43. Wehr KL, Johnson RL. Maximal oxygen consumption in patients with lung diseases. J Clin Invest 58: 880-890, 1976.
44. West JB. Diffusing capacity of the lungs for carbon monoxide at high altitude. J Appl Physiol 17: 421-426, 1962.
45. West JB. The physiologic basis of high altitude disease. Ann Intern Med 141: 789-800, 2004. (Pubitemid 39524917)
46. Winer BJ, Brown DR, Michels KM. Statistical Principles in Experimental Design (3rd ed.). New York, NY: McGraw-Hill, 1991, p. 220-283.
47. Zanen P, van der Lee L, van der Mark T, van den Bosch JM. Reference values for alveolar membrane diffusion capacity and pulmonary capillary blood volume. Eur Respir J 18: 764-769, 2001. (Pubitemid 33076917)
48. Zavorsky GS, Lands LC. Lung diffusion capacity for nitric oxide and carbon monoxide is impaired similarly following short-term graded exercise. Nitric Oxide 12: 31-38, 2005. (Pubitemid 41071407)
49. Zavorsky GS. Evidence of pulmonary oedema triggered by exercise in healthy humans and detected with various imaging techniques. Acta Physiol (Oxf) 189: 305-317, 2007. (Pubitemid 46426924)
50. Zavorsky GS. No red cell resistance to NO? I think not! J Appl Physiol 108: 1027-1029, 2010.
51. Zavorsky GS, Wilson B, Harris JK, Kim DJ, Carli F, Mayo NE. Pulmonary diffusion and aerobic capacity: Is there a relation? Does obesity matter? Acta Physiol 198: 499-507, 2010.